Hypokalemia in children with severe falciparum malaria

Kathryn Maitland1, Allan Pamba, Charles R J C Newton

  • 1Centre for Geographic Medicine Research, Coast, KEMRI, Kenya.

Insights

Hypokalemia is a common complication in children with severe malaria and acidosis, often not evident upon admission. Plasma potassium drops rapidly as acidosis is corrected, necessitating careful monitoring.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Nephrology

Background:

  • Severe malaria is associated with acidosis, a predictor of mortality.
  • Plasma potassium alterations frequently accompany acidosis in severe malaria.
  • Limited data exists on potassium changes during severe malaria.

Purpose of the Study:

  • To investigate plasma potassium changes in Kenyan children with severe malaria and acidosis within 24 hours of admission.
  • To assess renal potassium excretion and gradients at the time of admission.

Main Methods:

  • Prospective study of 38 Kenyan children with severe malaria and acidosis (base deficit >8).
  • Plasma potassium levels, urinary fractional excretion of potassium, and transtubular potassium gradient were measured on admission.
  • Interventions included standard severe malaria therapy, fluid resuscitation, and potassium replacement for hypokalemia.

Main Results:

  • At admission, 81.6% had normal serum potassium, 11% were hypokalemic, and 6.3% were hyperkalemic.
  • Within 4-8 hours of admission, 40% of patients became hypokalemic (<3 mmol/L), with 13% having levels <2.5 mmol/L.
  • Elevated urinary fractional excretion and transtubular potassium gradient indicated renal potassium loss.

Conclusions:

  • Hypokalemia is a frequent complication of severe malaria, often masked on admission.
  • Rapid potassium decrease occurs with acidosis correction, highlighting the need for serial monitoring.
  • Close monitoring of serum potassium is crucial for managing severe malaria patients with acidosis.
Abstract

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...